NYSE$ZEPP
ZEPP Health Corp.-ADR · Q1 2025 earnings
Q1 2025 earnings · · After market close · Investor relations
Briefing
Zepp Health Corporation reported a decrease in revenue but an increase in gross margin for the first quarter of 2025, with Amazfit-branded products showing growth.
Zepp Health Corporation's first quarter 2025 results showed total revenue of $38.5 million, a 3.6% decrease year-over-year, primarily due to lower Xiaomi wearable product sales. However, Amazfit-branded products saw a 10.2% year-over-year revenue growth. The company achieved a gross margin of 37.3% and reported a net loss of $19.7 million.
- Revenue for the first quarter of 2025 was US$38.5 million, a 3.6% decrease from the first quarter of 2024.
- Amazfit-branded products revenue grew by 10.2% year-over-year, marking a return to growth since Q1 2022.
- Gross margin improved to 37.3% in Q1 2025, higher than both Q4 2024 and Q1 2024.
- Net loss attributable to Zepp Health Corporation was US$19.7 million, compared to US$14.8 million in Q1 2024.
Headline financials
Revenue & EPS history
ZEPP Health · Revenue · Quarterly
$38.5M
Forward guidance
For the second quarter of 2025, Zepp Health expects net revenues to be between US$50 million and US$55 million, representing a significant year-over-year increase.
Tailwinds
- Expected net revenue increase of approximately 23% to 35% from US$40.6 million in Q2 2024.
- Anticipated higher sales for Amazfit Active 2 and Bip 6 series.
- Continued growth in Amazfit-branded sales with many new product launches in the pipeline.
- Commitment to investing in new technologies and AI to maintain competitive edge.
- Share-repurchase program remains in place, underscoring confidence in outlook.
Headwinds
- Outlook based on current market conditions and preliminary estimates, subject to change.
- First quarter is traditionally the lowest sales season for consumer electronics industry.
- Supply constraints, especially on long lead-time components, impacted Q1 2025.
- Fixed expenses were not fully absorbed in the low season, limiting gross-margin leverage in Q1.
- Additional 20% tariffs on China-made products impacted gross margin in Q1 2025.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q1 2025
-2.3%
Avg return
Earnings day
-3.4%
Avg return
5 days after
+1.6%
Avg return
30 days after
24%
9 / 37 earnings
Positive
+32.6%
Q2 2025
Best reaction
-29.3%
Q1 2027
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2027 | -29.3% | -24.1% | — | |
| Q1 2026 | +0.0% | -1.4% | -44.9% | |
| Q4 2026 | -12.1% | -17.3% | -13.5% | |
| Q3 2025 | -6.1% | -39.6% | -22.9% | |
| Q2 2025 | +32.6% | +91.2% | +312.8% | |
| Q1 2025 | -5.1% | -10.2% | -15.8% | |
| Q4 2024 | +15.3% | +2.7% | -9.7% | |
| Q3 2024 | -14.9% | -19.7% | -8.7% | |
| Q2 2024 | +19.7% | -3.3% | +10.0% | |
| Q1 2024 | -6.2% | -13.5% | -22.5% | |
| Q4 2023 | -8.5% | -17.0% | -29.4% | |
| Q3 2023 | +9.8% | -5.7% | +12.2% | |
| Q2 2023 | -4.2% | -5.8% | -6.7% | |
| Q1 2023 | -11.2% | -14.9% | -16.4% | |
| Q4 2022 | -6.9% | -11.5% | -11.5% | |
| Q3 2022 | -4.5% | -7.0% | +21.0% | |
| Q2 2022 | -9.1% | -7.2% | -28.8% | |
| Q1 2022 | -8.2% | -6.8% | -9.5% | |
| Q4 2021 | -0.6% | -1.3% | -15.1% | |
| Q3 2021 | -5.8% | -9.3% | -46.4% | |
| Q2 2021 | -1.0% | +10.7% | -5.6% | |
| Q1 2021 | -3.4% | +3.9% | +13.8% | |
| Q4 2020 | -2.1% | -10.2% | -28.6% | |
| Q3 2020 | -11.3% | -16.4% | -18.4% | |
| Q2 2020 | -11.1% | -8.8% | -4.2% | |
| Q1 2020 | -16.7% | -19.9% | -19.7% | |
| Q4 2019 | -5.2% | +1.7% | -2.8% | |
| Q3 2019 | +5.0% | +13.9% | +10.1% | |
| Q2 2019 | -1.5% | -14.0% | -5.7% | |
| Q1 2019 | +8.7% | +18.3% | +35.3% | |
| Q4 2018 | -7.9% | -13.9% | -18.1% | |
| Q3 2018 | -6.8% | +7.6% | -1.8% | |
| Q2 2018 | +9.1% | +4.7% | +0.4% | |
| Q1 2018 | +18.8% | +21.8% | +20.5% | |
| Q4 2015 | -1.5% | -0.9% | +21.6% | |
| Q4 2016 | -1.5% | -0.9% | +21.6% | |
| Q4 2017 | +0.1% | -0.5% | -15.3% | |
| Q3 2017 | — | — | — | |
| Q2 2017 | — | — | — | |
| Q1 2017 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro